Literature DB >> 9817064

[Surgical excision of pulmonary metastasis of cancer of the breast: apropos of 40 patients].

A Livartowski1, A Chapelier, P Beuzeboc, A Dierick, B Asselain, P Dartevelle, P Pouillart.   

Abstract

Between 1987 and 1995, 52 breast cancer patients had a surgical resection of lung secondaries. In 40 patients, the diagnosis of metastatic breast cancer could be confirmed following pathological examination. Five-year survival rates of these 40 patients was 54 +/- 8% and 5-year disease free survival was 30 +/- 8%. The median survival (70 months) of these patients was better than that of 57 patients with isolated lung metastases who had been treated conservatively (chemo- or/and hormonotherapy) during the same time interval. Twenty-six patients benefitted from a radical excision and had a longer disease free interval (42 versus 27 months, p = 0.03) than patients who had had a wedge resection. Overall survival was not significantly different (71 versus 41 months, p = 0.07). We feel that isolated lung nodules may best be treated by radical (segment or lobe) excision, in particular since preoperative differential diagnosis with primary lung cancer may be difficult. In the presence of multiple nodules, first line medical treatment by chemo- or hormonotherapy should be advocated, allowing to reduce the tumor load and to optimize survival in association with surgery.

Entities:  

Mesh:

Year:  1998        PMID: 9817064

Source DB:  PubMed          Journal:  Bull Cancer        ISSN: 0007-4551            Impact factor:   1.276


  3 in total

Review 1.  International guidelines for management of metastatic breast cancer: can metastatic breast cancer be cured?

Authors:  Olivia Pagani; Elzbieta Senkus; William Wood; Marco Colleoni; Tanja Cufer; Stella Kyriakides; Alberto Costa; Eric P Winer; Fatima Cardoso
Journal:  J Natl Cancer Inst       Date:  2010-03-10       Impact factor: 13.506

2.  Hormone receptor status may impact the survival benefit of surgery in stage iv breast cancer: a population-based study.

Authors:  Yinuo Tan; Xiaofen Li; Haiyan Chen; Yeting Hu; Mengjie Jiang; Jianfei Fu; Ying Yuan; Kefeng Ding
Journal:  Oncotarget       Date:  2016-10-25

Review 3.  Cure in metastatic breast cancer.

Authors:  Theresa Westphal; Simon Peter Gampenrieder; Gabriel Rinnerthaler; Richard Greil
Journal:  Memo       Date:  2018-08-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.